PolyPeptide Group AG
PPGN | SW
Overview
Corporate Details
- ISIN(s):
- CH1110760852
- LEI:
- 5067007JCKTPOX4G9758
- Country:
- Switzerland
- Address:
- Neuhofstrasse 24, 6340 Baar
- Website:
- https://www.polypeptide.com/
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with around 1,100 employees at the end of 2021, its diversity brings breadth, depth of knowledge and experience to the group. PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-23 07:00 |
Capital/Financing Update
PolyPeptide announces expansion of existing credit facilities
|
English | 7.8 KB | |
| 2025-05-23 02:00 |
Capital/Financing Update
PolyPeptide announces expansion of existing credit facilities
|
English | 6.0 KB | |
| 2025-05-23 02:00 |
Capital/Financing Update
PolyPeptide gibt Ausweitung des bestehenden Kreditrahmens bekannt
|
German | 7.0 KB | |
| 2025-04-09 18:34 |
Regulatory News Service
PolyPeptide announces results of the annual General Meeting 2025
|
English | 9.3 KB | |
| 2025-03-19 07:00 |
Regulatory News Service
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | |
| 2025-03-18 07:00 |
Regulatory News Service
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | |
| 2025-03-18 01:00 |
Inside Information Statement
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 7.1 KB | |
| 2025-03-18 01:00 |
Inside Information Statement
PolyPeptide publiziert Einladung zur ordentlichen Generalversammlung 2025
|
German | 8.0 KB | |
| 2025-03-12 06:55 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 32.1 KB | |
| 2025-03-11 06:55 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 32.1 KB | |
| 2025-03-11 01:00 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 28.2 KB | |
| 2025-03-11 01:00 |
Earnings Release
PolyPeptide mit substantiellen Verbesserungen bei Profitabilität und Cashflow, …
|
German | 32.0 KB | |
| 2025-01-09 07:00 |
Regulatory News Service
Doubling of production capacity at the manufacturing site in Malmo
|
English | 8.9 KB | |
| 2025-01-08 07:00 |
Regulatory News Service
Doubling of production capacity at the manufacturing site in Malmo
|
English | 8.9 KB | |
| 2025-01-08 01:00 |
Regulatory News Service
Doubling of production capacity at the manufacturing site in Malmö
|
English | 6.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 35,000.00 CHF |
| 2023-11-10 | N/A | Executive member | Buy | None | 51,250.00 CHF |
| 2023-10-11 | N/A | Executive member | Buy | None | 2,876,348.62 CHF |
| 2023-10-10 | N/A | Executive member | Buy | None | 371,202.96 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Allmed Solutions Ltd. | Israel | ALMD | |
|
Biosynex | France | ALBIO | |
|
Bio-Works Technologies AB | Sweden | BIOWKS | |
|
Bonesupport Holding | Sweden | BONEX | |
|
Coloplast | Denmark | COLO | |
|
COLTENE Holding AG | Switzerland | CLTN | |
|
Convatec Group PLC | United Kingdom | CTEC | |
|
Cosma Spolka Akcyjna | Poland | COS | |
|
EssilorLuxottica | France | EL | |
|
Euromedis Groupe | France | ALEMG |